Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Management of Dry Eye Syndrome | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Magnetic Resonance Spectroscopy | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lyme Disease Intravenous Antibiotic Therapy and Associated Diagnostic Testing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lutetium Lu 177 vipivotide tetraxetan (e.g., Pluvicto) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Luspatercept-aamt (e.g., Reblozyl) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lurbinectedin (e.g., Zepzelca) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lung Volume Reduction Surgery (LVRS) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lumbar Artificial Vertebral Disc | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lumasiran (e.g., Oxlumo) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Low-Dose Radiotherapy (LDRT) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Low Level Laser Therapy (LLLT) and High Intensity Laser Therapy | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lovotibeglogene autotemcel (e.g., Lyfgenia) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Loncastuximab tesirine-lpyl (e.g., Zynlonta) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Laser Interstitial Thermal Therapy for Neurological Conditions | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lisocabtagene Maraleucel (e.g., Breyanzi) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Linvoseltamab-gcpt (e.g., Lynozyfic) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lifileucel (e.g., Amtagvi) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Levoleucovorin Calcium (e.g., Khapzory) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Levodopa-carbidopa Intestinal Gel (e.g., Duopa) for Treatment of Advanced Parkinson’s Disease | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Leuprolide Acetate (e.g., Lupron Depot; Fensolvi) for Non-Oncologic Indications | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Leuprolide (e.g., Lupron) for Oncologic Indications | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Letermovir (e.g., Prevymis) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lenacapavir (e.g., Sunlenca) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Left Atrial Appendage Occlusion, Closure Devices | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Leadless Cardiac Pacemakers | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Laser Treatment of Congenital Port Wine Stain Hemangiomas and Burn Scars | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Laser Treatment of Onychomycosis | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Use of Laser Therapy or Radiofrequency Therapy for the Treatment of Vaginal Atrophy or Vaginal Relaxation Syndrome | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Laser or Radiofrequency Treatment, Chronic Back Pain | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lanreotide (e.g., Lanreotide injection, Somatuline depot) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lab Test: Serum Vitamin D Levels | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lab Test: Identification of Microorganisms Using Nucleic Acid Probes | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Lab Test: Fecal Calprotectin Testing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Laboratory Tests for Chronic Heart Failure and Organ Transplant Rejection | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Keratoprosthesis | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Isatuximab-irfc (e.g., Sarclisa) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Irreversible Electroporation, Nanoknife | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Iron Therapy, Parenteral | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Irinotecan Liposomal (e.g., Onivyde) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Ipilimumab (e.g., Yervoy) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Iobenguane I 131 (e.g., Azedra) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Laboratory Testing Investigational Services | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Intravitreal, Punctum Corticosteroid Implants (e.g., Retisert, Yutiq, Iluvien, Ozurdex, and Dextenza) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Intravenous Lidocaine or Ketamine for the Outpatient Management of Chronic Pain and Mental Health Disorders | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Intraoperative Radiation Therapy | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Intraoperative Neurophysiologic Monitoring | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Intraoperative Assessment of Tissue | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Intraocular Radiotherapy for Age-Related Macular Degeneration | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Intraepidermal Nerve Fiber Density | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Intracoronary Drug Delivery Balloon Procedures | New policy |